Drug intelligence / Profile preview

Perfectha Deep Lidocaine

Development stage
Unknown
Lead developer
Sinclair
Administration
Subcutaneous, Intradermal
01

Overview

Perfectha Deep Lidocaine is a hyaluronic acid-based dermal filler developed by Sinclair Pharmaceuticals, a subsidiary of Huadong Medicine. It is formulated as a sterile, resorbable, biphasic gel containing 20 mg/mL of cross-linked sodium hyaluronate and 0.3% lidocaine hydrochloride. The product utilizes Sinclair's proprietary E-BRID cross-linking technology to create uniform spherical microparticles that provide structural support and volumization when injected into the deep dermis or subcutaneous tissue. It is primarily indicated for the aesthetic treatment of deep facial wrinkles and volume loss, such as nasolabial folds, marionette lines, and temple hollowing. The lidocaine component acts as a local anesthetic to reduce patient discomfort during the injection process. As a Class III medical device, it provides results that typically last between 6 and 18 months.

Brand names
Perfectha Deep Lidocaine
Other names
Perfectha Deep with Lidocaine
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Perfectha Deep Lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perfectha Deep Lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call